Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have agreed in writing to have their personal information collected and used, after being given a full explanation of the study's purpose and methods.
- People who have been confirmed through a tissue biopsy or similar test to have primary breast cancer (cancer that started in the breast, not spread from elsewhere), and either need chemotherapy before surgery or chemotherapy after breast cancer surgery.
- People who are planned to receive a specific chemotherapy drug called docetaxel, using a formulation that does not contain ethanol (alcohol).
- People who are able to understand the study, cooperate with its requirements, and continue participating until it is finished.
Who may not be able to join:
- People who have been diagnosed with another type of primary cancer (a separate cancer, not related to the breast cancer) that could affect their breast cancer treatment or outcomes.
- People whose breast cancer has been identified as a secondary cancer — meaning a cancer that has spread to the breast from another part of the body.
- People whose breast cancer is classified as Stage 0 or Stage I (very early stage) or Stage IV (cancer that has spread to other parts of the body beyond the breast and nearby lymph nodes).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-2-708-8000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of ethanol-induced symptoms in the initial cycle
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.